publicação venue de
- Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival. 000:1-276.e7. 2023-01-01
- Donor-specific HLA antibodies are associated with graft failure and delayed hematologic recovery after unrelated donor hematopoietic cell transplantation. 29:493.e1-493.e10. 2023-01-01
- Immunogenicity and Safety of a Heterologous COVID-19 Vaccine Regimen in Hematopoietic Stem Cell Transplant Recipients. 29:S331-S332. 2023-01-01
- Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis by Prior Transplantation. 29:134.e1-134.e7. 2023-01-01
- Long-Term Follow-up of AUTO1, a Fast-Off Rate CD19 CAR, in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia and Factors Associated with Durable Response. 29:S213-S214. 2023-01-01
- ATG in HLA-Matched, Peripheral Blood, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Secondary Analysis of a CIBMTR Database. 1:1. 2022-01-01
- Comparison of the Overall Survival (OS) Predicted By the Center International for Bone Marrow Transplantation Research (CIBMTR) Calculator with the Actual Outcome of a FACT-Accredited Hematopoietic Stem Cell Transplantation (HSCT) Center in Brazil. 28:S455. 2022-01-01
- DIPSS Score Validation As a Tool to Estimate Survival and Non-Relapse Mortality after Hematopoietic Stem Cell Transplant in a Brazilian Multicentric Cohort. 28:S131-S133. 2022-01-01
- Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?. 1:01434-01438. 2022-01-01
- Is Severity Score Associated for Hematopoietic Stem Cell Transplantation in Individuals with Sickle cell Anemia?. 000:1-8. 2022-01-01
- Mature naive B cells regulate the outcome of murine acute graft-versus-host disease in an IL-10 independent manner. 181:1-181.e9. 2022-01-01
- Predictive Factors and Outcomes After Allogeneic Stem-Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil. 1:1-10. 2022-01-01
- Targeted Marrow Irradiation Intensification of Reduced Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation. 1:1. 2022-01-01
- The Impact of FACT Accreditation Program in a Bone Marrow Transplantation Unit in Latin America: Improving Clinical Results. 28:S449. 2022-01-01
- Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation. 28:46.e1-46.e7. 2022-01-01
- Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders. 28:698.e1-698.e11. 2022-01-01
- Viral Infections in Unrelated Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Compared with the Use of Thymoglobulin. 28:S378. 2022-01-01
- Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study. 27:78.e1-78.e6. 2021-01-01
- Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation. 27:270.e1-270.e6. 2021-01-01
- Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation. 27:926.e1-926.e10. 2021-01-01
- Early versus Late Fluconazole Prophylaxis in Autologous Hematopoietic Cell Transplantation. 27:681.e1-681.e5. 2021-01-01
- Long-Term Follow-Up of Ruxolitinib in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease. 27:777.e1-777.e6. 2021-01-01
- Outcomes after haploidentical cell transplantation with posttransplant cyclophosphamide: a systematic review and meta-analysis comparing myeloablative with reduced-intensity conditioning regimen and bone marrow with peripheral blood stem-cell graft: PTCy: PBSC or BM and MAC or RIC for Haplo-HCT with PTCy. 1:1-10. 2021-01-01
- Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia. 27:424.e1-424.e9. 2021-01-01
- Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). 27:274.e1-274.e5. 2021-01-01